Combination Therapy to Prevent Cardiovascular Disease Journal Articles

authors

• Smith, Richard
• McCready, Tara
• Yusuf, Salim

status

• published 

publication date

• April 17, 2013

has subject area

• 11 Medical and Health Sciences (FoR)
• Antihypertensive Agents (MeSH)
• Aspirin (MeSH)
• Cardiovascular Diseases (MeSH)
• Cost Control (MeSH)
• Drug Combinations (MeSH)
• Drug Costs (MeSH)
• Drug Industry (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
• Mass Screening (MeSH)
• Medication Adherence (MeSH)
• Platelet Aggregation Inhibitors (MeSH)
• Practice Patterns, Physicians' (MeSH)
• Primary Prevention (MeSH)
• Secondary Prevention (MeSH)
• Treatment Outcome (MeSH)

published in

• Journal of the American Medical Association (JAMA)  Journal

keywords

• Antihypertensive Agents
• Aspirin
• Cardiovascular Diseases
• Cost Control
• Drug Combinations
• Drug Costs
• Drug Industry
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Mass Screening
• Medication Adherence
• Platelet Aggregation Inhibitors
• Practice Patterns, Physicians'
• Primary Prevention
• Secondary Prevention
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1001/jama.2013.3180

PubMed ID

• 23529576

start page

• 1595

end page

• 1595

volume

• 309

issue

• 15